AtaCor Medical Announces First Patient Treated Globally in its ALARION-EV Pivotal Trial
/
DateJul 07 2026
Study will evaluate AtaCor’s investigational Atala™ lead in conjunction with Abbott’s investigational EV-ICD pulse generator Study will evaluate a novel parasternal extravascular ICD approach for... Read More →



















